UG Healthcare (Catalist:8K7) - Cotización, noticias y análisis

Resumen de acción 8K7

UG Healthcare Corporation Limited, un holding de inversiones, fabrica y vende guantes desechables.

8K7 fundamental analysis
Snowflake Score
Valuation	2/6
Future Growth	0/6
Past Performance	0/6
Financial Health	4/6
Dividends	0/6

Recompensas

Análisis de riesgos

Los beneficios han disminuido un 5% al año en los últimos 5 años

No tiene una capitalización de mercado significativa (SGD70M)

Competidores de UG Healthcare Corporation Limited

Medtecs International

Catalist:546

S$70.3m

Riverstone Holdings

SGX:AP4

S$1.2b

Vicplas International

SGX:569

S$58.8m

Econ Healthcare (Asia)

Catalist:EHG

S$51.6m

Historial de precios y rendimiento

Summary of all time highs, changes and price drops for UG Healthcare
Historical stock prices
Current Share Price	S$0.11
52 Week High	S$0.23
52 Week Low	S$0.086
Beta	0.76
1 Month Change	0%
3 Month Change	-20.29%
1 Year Change	-31.25%
3 Year Change	-84.72%
5 Year Change	83.34%
Change since IPO	32.00%

Noticias y actualizaciones recientes

Recent updates

Rentabilidad de los accionistas

	8K7	SG Medical Equipment	Mercado SG
7D	0%	5.4%	2.9%
1Y	-31.3%	-8.7%	-3.9%

Rentabilidad vs. Industria: 8K7 obtuvo unos resultados inferiores a los del sector SG Medical Equipment , que el año pasado arrojó un rendimiento del -7.8%.

Rentabilidad vs. Mercado: 8K7 obtuvo unos resultados inferiores a los del mercado SG, que fue del -4.1% el año pasado.

Volatilidad de los precios

Is 8K7's price volatile compared to industry and market?
8K7 volatility
8K7 Average Weekly Movement	5.4%
Medical Equipment Industry Average Movement	6.3%
Market Average Movement	5.0%
10% most volatile stocks in SG Market	15.5%
10% least volatile stocks in SG Market	2.2%

Precio estable de las acciones: El precio de las acciones de 8K7 ha sido volátil en los últimos 3 meses.

Volatilidad a lo largo del tiempo: La volatilidad semanal de 8K7 ha disminuido de 11% a 5% en el último año.

Acerca de la empresa

Fundada	Empleados	CEO	Página web
1989	1,054	Keck Keong Lee	www.ughealthcarecorporation.com

UG Healthcare Corporation Limited, un holding de inversiones, fabrica y vende guantes desechables. La empresa opera a través de tres segmentos: Guantes de examen de látex, Guantes de examen de nitrilo y Otros productos auxiliares. Distribuye productos auxiliares, como guantes quirúrgicos, guantes desechables de vinilo y para salas limpias, mascarillas y otros productos médicos desechables; fabrica guantes de goma; y presta servicios de consultoría empresarial y de gestión.

Resumen de fundamentos de UG Healthcare Corporation Limited

¿Cómo se comparan los beneficios e ingresos de UG Healthcare con su capitalización de mercado?
Estadísticas fundamentales de 8K7
Capitalización bursátil	S$68.62m
Beneficios(TTM)	-S$20.93m
Ingresos (TTM)	S$94.93m

0.7x

Ratio precio-ventas (PS)

-3.3x

Ratio precio-beneficio (PE)

¿Está 8K7 sobrevalorada?

Ver valor justo y análisis de valoración

Beneficios e Ingresos

Estadísticas clave de rentabilidad del último informe de resultados (TTM)
Cuenta de resultados (TTM) de 8K7
Ingresos	S$94.93m
Coste de los ingresos	S$91.50m
Beneficio bruto	S$3.43m
Otros gastos	S$24.36m
Beneficios	-S$20.93m

Últimos beneficios comunicados

Dec 31, 2023

Próxima fecha de beneficios

n/a

Beneficios por acción (BPA)	-0.034
Margen bruto	3.61%
Margen de beneficio neto	-22.05%
Ratio deuda/patrimonio	15.9%

¿Cómo se ha desempeñado 8K7 a largo plazo?

Ver rendimiento histórico y comparativa

Resumen de acción 8K7

Recompensas

Análisis de riesgos

Competidores de UG Healthcare Corporation Limited

Catalist:546

S$70.3m

SGX:AP4

S$1.2b

SGX:569

S$58.8m

Catalist:EHG

S$51.6m

Historial de precios y rendimiento

Noticias y actualizaciones recientes

First half 2024 earnings released: S$0.008 loss per share (vs S$0.008 loss in 1H 2023)

New major risk - Revenue and earnings growth

UG Healthcare Corporation Limited to Report First Half, 2024 Results on Feb 13, 2024

UG Healthcare Corporation Limited Announces Appointment of Ng Lee Eng as Independent Non-Executive Director Chairman of Nominating Committee Member of Audit Committee Member of Remuneration Committee

New minor risk - Share price stability

UG Healthcare Corporation Limited Announces Cessation Vincent Leow as Independent Non-Executive Director Chairman of Nominating Committee Member of Audit Committee Member of Remuneration Committee

Recent updates

First half 2024 earnings released: S$0.008 loss per share (vs S$0.008 loss in 1H 2023)

New major risk - Revenue and earnings growth

UG Healthcare Corporation Limited to Report First Half, 2024 Results on Feb 13, 2024

UG Healthcare Corporation Limited Announces Appointment of Ng Lee Eng as Independent Non-Executive Director Chairman of Nominating Committee Member of Audit Committee Member of Remuneration Committee

New minor risk - Share price stability

UG Healthcare Corporation Limited Announces Cessation Vincent Leow as Independent Non-Executive Director Chairman of Nominating Committee Member of Audit Committee Member of Remuneration Committee

Full year 2023 earnings released: S$0.033 loss per share (vs S$0.059 profit in FY 2022)

UG Healthcare Corporation Limited, Annual General Meeting, Oct 30, 2023

Full year 2023 earnings released: S$0.033 loss per share (vs S$0.059 profit in FY 2022)

New minor risk - Financial data availability

First half 2023 earnings released: S$0.008 loss per share (vs S$0.034 profit in 1H 2022)

UG Healthcare Corporation Limited to Report First Half, 2023 Results on Feb 14, 2023

Less than half of directors are independent

UG Healthcare Corporation Limited Approves Special Cash Dividend for the Financial Year Ended 30 June 2022, Payable on 16 December 2022

UG Healthcare Corporation Limited (Catalist:8K7) entered into a share sale agreement to acquire Indigo Teguh Sdn Bhd from Lee Keck Keong for MYR 100.

Full year 2022 earnings: EPS and revenues exceed analyst expectations

UG Healthcare Corporation Limited, Annual General Meeting, Oct 28, 2022

Consensus revenue estimates fall by 12%

Full year 2022 earnings: EPS and revenues exceed analyst expectations

UG Healthcare Corporation Limited Recommends Tax Exempt Special Dividend for Fiscal Year 2022

Less than half of directors are independent

Now 20% undervalued after recent price drop

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

UG Healthcare Corporation Limited to Report First Half, 2022 Results on Feb 11, 2022

UG Healthcare Corporation Limited to Report First Half, 2022 Results on Feb 11, 2022

Price target decreased to S$0.44

Full year 2021 earnings released: EPS S$0.19 (vs S$0.023 in FY 2020)

Price target decreased to S$0.55

Less than half of directors are independent

UG Healthcare Corporation Limited Provides Update on Covid-19 Situation in the Group's Manufacturing Division in Malaysia

Company Secretary Kar Yeoh has left the company

Third quarter 2021 earnings released: EPS S$0.056 (vs S$0.011 in 3Q 2020)

Price target decreased to S$0.99

Second quarter 2021 earnings released

UG Healthcare Corporation Limited to Report First Half, 2021 Results on Feb 04, 2021

New 90-day low: S$0.36

New 90-day low: S$0.23

New 90-day low: S$0.60

New 90-day low: S$0.64

First quarter 2021 earnings released: EPS S$0.039

Analysts update estimates

Annual earnings released: Revenue and earnings beat expectations

Full year earnings released - EPS S$0.023

Analysts increase revenue estimates to S$240.3m

UG Healthcare Corporation Limited has completed a Follow-on Equity Offering in the amount of SGD 19.0875 million.

Analysts increase revenue estimates to S$180.9m

Full year earnings released - EPS S$0.068

New 90-day high - S$2.91

Rentabilidad de los accionistas

Volatilidad de los precios

Acerca de la empresa

Resumen de fundamentos de UG Healthcare Corporation Limited

0.7x

-3.3x

Beneficios e Ingresos